Experimental and Clinical Trials of New99mTc-Labeled Hepatobiliary Agents
Authors:
- Brian W. WistowBWBrian W. Wistow
- Gopal SubramanianGSGopal Subramanian
- George M. GagneGGGeorge M. Gagne
- Robert W. HendersonRHRobert W. Henderson
- John G. McAfeeJMJohn G. McAfee
- Robert C. HallRHRobert C. Hall
- Zachary D. GrossmanZGZachary D. Grossman
- 1 September 1978
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 128 (3) , 793-794
Abstract
Several new derivatives of lidocaine were synthesized and used to examine the intra- and extrahepatic bile ducts and gallbladder. Diisopropyl-IDA exhibited approximately twice the bile concentration of 131I-rose bengal during the first hour after injection. P-butyl-IDA also concentrates moderately well in the bile and has the added advantage of very low excretion into the urine (2%). It seems more effective than the other IDA derivatives at high bilirubin levels.Keywords
This publication has 3 references indexed in Scilit: